NVAX ▲ +0.9% - Novavax, Inc.
$NVAX NVAX - Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe
29-OCT-2026 09:38 AM ET
Share this post
More filings for $NVAX
NVAX ▼ -0.4% - Novavax, Inc.Oct 29, 2026NVAX - Novavax, Inc. - SEC Filing Update (16-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 16, 2026NVAX ▲ +25.9% - Novavax, Inc.Oct 5, 2026NVAX ▲ +16.2% - Novavax, Inc.Oct 5, 2026NVAX ▲ +7.0% - Novavax, Inc.Oct 5, 2026NVAX ▲ +1.1% - Novavax, Inc.Sep 2, 2026
View full $NVAX filing history →💬 Comments
Loading comments…
Leave a comment